ATE145551T1 - Brausedosisform sowie verfahren zu deren verabreichung - Google Patents

Brausedosisform sowie verfahren zu deren verabreichung

Info

Publication number
ATE145551T1
ATE145551T1 AT90915661T AT90915661T ATE145551T1 AT E145551 T1 ATE145551 T1 AT E145551T1 AT 90915661 T AT90915661 T AT 90915661T AT 90915661 T AT90915661 T AT 90915661T AT E145551 T1 ATE145551 T1 AT E145551T1
Authority
AT
Austria
Prior art keywords
administration
dosage form
effervescent dosage
present
effervescent
Prior art date
Application number
AT90915661T
Other languages
English (en)
Inventor
Fred Wehling
Steve Schuehle
Navayanarao Madamala
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Application granted granted Critical
Publication of ATE145551T1 publication Critical patent/ATE145551T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90915661T 1989-10-02 1990-09-13 Brausedosisform sowie verfahren zu deren verabreichung ATE145551T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41615289A 1989-10-02 1989-10-02
US50764290A 1990-04-11 1990-04-11
CA002061917A CA2061917C (en) 1989-10-02 1992-02-26 Pediatric effervescent dosage form

Publications (1)

Publication Number Publication Date
ATE145551T1 true ATE145551T1 (de) 1996-12-15

Family

ID=27169031

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90915661T ATE145551T1 (de) 1989-10-02 1990-09-13 Brausedosisform sowie verfahren zu deren verabreichung

Country Status (9)

Country Link
EP (2) EP0494972B1 (de)
JP (2) JP3412694B2 (de)
AT (1) ATE145551T1 (de)
AU (1) AU646232B2 (de)
CA (1) CA2061917C (de)
DE (1) DE69029273T2 (de)
DK (1) DK0494972T3 (de)
ES (1) ES2097155T3 (de)
WO (1) WO1991004757A1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
DE4317646A1 (de) * 1993-05-27 1994-12-01 Asta Medica Ag Tabletten mit Thioctsäure und mindestens einer basischen Komponente
FR2715849B1 (fr) * 1994-02-09 1996-04-05 Xavier Hesnard Forme d'administration solide à délitescence rapide d'un principe actif.
EP0762869A1 (de) * 1994-06-03 1997-03-19 The Procter & Gamble Company Schnelllöslische dosierungsformen
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
CA2222176A1 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Compliance support package for increasing health management system compliance
US6039978A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Dietary food enhancement agent
US6039989A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
CA2223102A1 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Therapeutic system for dietary health management
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
ATE188376T1 (de) * 1995-07-31 2000-01-15 Gerhard Gergely Kautablette mit brausewirkung
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
DE69727922T2 (de) * 1996-04-16 2005-01-20 Novartis Consumer Health S.A. Schnell zerfallende orale dosierungsform
BR9711585A (pt) * 1996-10-01 2000-01-18 Cima Labs Inc Composição de microcápsula, com sabor mascarado, de um remédio solúvel em água, formulação farmacêutica para administrar um remédio, e, processo para disfarçar o sabor de um remédio.
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
DE19723042C2 (de) * 1997-06-02 1999-07-01 Rudy Thoma Iod enthaltende Süßstoffzubereitung
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
EP1001748B1 (de) * 1997-07-25 2006-04-19 Alpex Pharma S.A. Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
FR2774291B1 (fr) * 1998-02-03 2000-04-21 Innothera Lab Sa Specialite pharmaceutique sous forme galenique unitaire de comprimes a croquer ou a sucer, comprenant comme principe actif du fer element
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6576250B1 (en) 1998-03-27 2003-06-10 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
DE19814392A1 (de) * 1998-03-31 1999-10-07 Hermes Fabrik Pharm Praeparate Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff
FR2787715B1 (fr) * 1998-12-23 2002-05-10 Synthelabo Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
US6680071B1 (en) 1999-03-03 2004-01-20 R. P. Scherer Technologies, Inc. Opioid agonist in a fast dispersing dosage form
AU2007203233B2 (en) * 1999-03-26 2010-02-25 Cima Labs Inc. Sublingual buccal effervescent
AU2004242477B2 (en) * 1999-03-26 2007-04-19 Cima Labs Inc. Sublingual buccal effervescent
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
JP5209160B2 (ja) 1999-08-24 2013-06-12 エービーアイシー・バイオロジカル・ラボラトリーズ・リミテッド ワクチン組成物およびその使用方法
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
TWI256309B (en) * 1999-10-13 2006-06-11 Akzo Nobel Nv New formulation of mirtazapine
KR100759720B1 (ko) 2000-06-30 2007-10-04 아스텔라스세이야쿠 가부시키가이샤 구강내 속붕괴정
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
US20040258748A1 (en) * 2001-09-25 2004-12-23 Ashish Madan Process for the preparation of fast dissolving dosage form
CN1655770A (zh) 2002-04-25 2005-08-17 旗帜药物胶囊公司 可咀嚼的软胶囊
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
FI20022007A0 (fi) 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
US8741348B2 (en) 2002-12-20 2014-06-03 Niconovum Ab Physically and chemically stable nicotine-containing particulate material
JP2007532623A (ja) 2004-04-12 2007-11-15 ファイザー・プロダクツ・インク 破裂型多重粒子中の味マスキング薬物
US20080279935A1 (en) * 2005-02-18 2008-11-13 Swg Invest As Composition Comprising a Powder Containing Microencapsulated Polyunsaturated Long-Chain Esterified Fatty Acids Distributed in an Effervescent Base
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
JP5535616B2 (ja) 2006-03-31 2014-07-02 ルビコン リサーチ プライベート リミテッド 口腔内崩壊錠剤のための直接圧縮性複合材
EP1897543A1 (de) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine-Waffel zur Substitutionstherapie
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US10357462B2 (en) 2006-11-30 2019-07-23 Ben Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
CA2617688C (en) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Solid dosage formulations containing weight-loss drugs
DE102007041588A1 (de) 2007-09-01 2009-03-05 Lts Lohmann Therapie-Systeme Ag Arzneimittel mit Hefe
JP2009137872A (ja) * 2007-12-05 2009-06-25 Lion Corp グルクロノラクトン含有経口用固形製剤
EP2384742A1 (de) 2010-05-03 2011-11-09 The Jordanian Pharmaceutical Manufacturing Co. Pharmazeutischer Trägerstoff, Verfahren zu dessen Herstellung und dessen Verwendung
JP5560104B2 (ja) * 2010-06-07 2014-07-23 ライオン株式会社 アスコルビン酸（塩）含有固形製剤
JP5697668B2 (ja) 2010-07-09 2015-04-08 帝人ファーマ株式会社 口腔内崩壊錠剤
CN107106603A (zh) * 2015-01-14 2017-08-29 辉瑞大药厂 口服产品
WO2018117855A1 (en) * 2016-12-20 2018-06-28 X-Ing As Effervescent lozenge
US11529492B2 (en) 2017-06-28 2022-12-20 Mayo Foundation For Medical Education And Research Methods and materials for treating hypocapnia
CN109303334B (zh) * 2018-10-17 2021-04-13 汤臣倍健股份有限公司 一种口腔微泡腾片及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB189403160A (de) *
US1262888A (en) 1917-02-20 1918-04-16 Albert Westlake Mouth-tablet.
US2887437A (en) 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US3042531A (en) 1959-12-09 1962-07-03 Leslie Salt Company Method of making a compressed tablet
SE369036B (de) * 1972-06-30 1974-08-05 Astra Laekemedel Ab
US3962417A (en) 1974-03-27 1976-06-08 Howell Charles J Dentifrice
US4613497A (en) 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
US4725427A (en) 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
GB8421226D0 (en) 1984-08-21 1984-09-26 Int Conferences Ab Tooth cleaning tablet
US4639368A (en) 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
GB8525348D0 (en) * 1985-10-15 1985-11-20 Nicholas Kiwi Pacific Pty Ltd Effervescent tablets
IE873172L (en) 1986-12-29 1988-06-29 Harvard College Continuous process for producing a comestible tablet
GB8724763D0 (en) 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
GB8909793D0 (en) 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
DE69029273D1 (de) 1997-01-09
EP0494972B1 (de) 1996-11-27
DE69029273T2 (de) 1997-06-12
JP3412694B2 (ja) 2003-06-03
JP2003231629A (ja) 2003-08-19
CA2061917A1 (en) 1993-08-27
AU646232B2 (en) 1994-02-17
EP0494972A1 (de) 1992-07-22
ES2097155T3 (es) 1997-04-01
CA2061917C (en) 1999-02-02
WO1991004757A1 (en) 1991-04-18
EP0737473A1 (de) 1996-10-16
DK0494972T3 (da) 1997-05-12
AU6601290A (en) 1991-04-28
JPH05500956A (ja) 1993-02-25
EP0494972A4 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
ATE145551T1 (de) Brausedosisform sowie verfahren zu deren verabreichung
MY128809A (en) Pharmaceutical formulation of omeprazole
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
MX9203480A (es) Formulaciones medicinales en aereosol.
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
ATA131091A (de) Orale feste pharmazeutische dosierungsform mit programmierter wirkstofffreisetzung und verfahren zu ihrer herstellung
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
ATA176789A (de) Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung
DK0459666T3 (da) Lægemidler mod impotens
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
DE68902300T2 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
FI945510A0 (fi) Klavulaanihapon diamiinisuolat
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DE3852332D1 (de) 4-Thiochinazolin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
DE3782378D1 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
DE68906461D1 (de) Feste arzneidosis in form eines tablettentriturats sowie verfahren zu deren herstellung.
IL88697A0 (en) Oral dosage units for pharmaceuticals and their use and preparation
DE3675378D1 (de) 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
PT100033A (pt) Produtos farmaceuticos contendo granisetron e dexametasona util no tratamento de nauseas e vomitos
DE69327247T2 (de) Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung
ATE49501T1 (de) Pharmazeutische zubereitungen in form von instantgranulaten oder -tabletten, sowie verfahren zu deren herstellung.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time